Home Study Details

    Program Type

    Home Study Webcast


    1 Contact Hour(s)

    Release Date

    Friday, January 7, 2022

    Offline Date

    Tuesday, January 7, 2025

    ACPE Expiration Date

    Tuesday, January 7, 2025

    Target Audience




    • Overview

      This session is part of the Opioid Module, which explores the safe and effective utilization of prescription opioids within diverse pain management treatment plans during the opioid crisis. This session reviews the additional study category for a medication to not only attain FDA-approval, but to additionally have FDA approval as an abuse deterrent formulation (ADF) prescription opioid medication. This session will review product selection and patient counseling points for the ADF prescription opioids that are FDA approved as an ADF opioid medication and actually available on the U.S. market.


      • Slide Document :   22027H08_2pp.pdf
      • Slide Document :   22027H08_6pp.pdf

      Financial Support By

    • Pharmacist

      Discuss common methods of manipulation of abuse-deterrent formulation (ADF) opioid medications
      Recall the available abuse-deterrent formulation (ADF) opioid medications, with particular attention to the select few that are both FDA approved specifically as ADF opioid medications and available on the U.S. market
      Identify the seven current types of abuse-deterrent formulations
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-22-027-H08-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).